Lindsey Cox, MDAssistant Professor of UrologyDepartment of Urology Medical University of South Carolina96 Jonathan Lucas St. CSB 620Charleston, SC 29425Eric S. Rovner, MDProfessor of UrologyDepartment of Urology Medical University of South Carolina96 Jonathan Lucas St. CSB 620Charleston, SC 29425

• Pathophysiology of Overactive Bladder.- Diagnosis of Overactive Bladder. The Placebo Effect in Overactive Bladder Syndrome.- Outcome Measures and Patient Expectations for Overactive Bladder.- National and International Guidelines in Overactive Bladder.- β3-Agonists for Overactive Bladder.- Combination Pharmacotherapy for Overactive Bladder.- Behavioral Therapy in Combination with Pharmacotherapy.- Pharmacotherapy for Nocturia.- Intravesical Chemodenervation and Toxins.- Other Treatment for Overactive Bladder, Including Intravesical.- Future Considerations in Overactive Bladder Pharmacotherapy.- Considerations in Pediatric Overactive Bladder.- Considerations in Male Overactive Bladder.- Considerations in the Medically Complex and Frail Elderly.- Individualizing Drug Therapy.

Lindsey Cox, MDAssistant Professor of UrologyDepartment of Urology Medical University of South Carolina96 Jonathan Lucas St. CSB 620Charleston, SC 29425Eric S. Rovner, MDProfessor of UrologyDepartment of Urology Medical University of South Carolina96 Jonathan Lucas St. CSB 620Charleston, SC 29425

• Pathophysiology of Overactive Bladder.- Diagnosis of Overactive Bladder. The Placebo Effect in Overactive Bladder Syndrome.- Outcome Measures and Patient Expectations for Overactive Bladder.- National and International Guidelines in Overactive Bladder.- β3-Agonists for Overactive Bladder.- Combination Pharmacotherapy for Overactive Bladder.- Behavioral Therapy in Combination with Pharmacotherapy.- Pharmacotherapy for Nocturia.- Intravesical Chemodenervation and Toxins.- Other Treatment for Overactive Bladder, Including Intravesical.- Future Considerations in Overactive Bladder Pharmacotherapy.- Considerations in Pediatric Overactive Bladder.- Considerations in Male Overactive Bladder.- Considerations in the Medically Complex and Frail Elderly.- Individualizing Drug Therapy.

Lindsey Cox, MDAssistant Professor of UrologyDepartment of Urology Medical University of South Carolina96 Jonathan Lucas St. CSB 620Charleston, SC 29425Eric S. Rovner, MDProfessor of UrologyDepartment of Urology Medical University of South Carolina96 Jonathan Lucas St. CSB 620Charleston, SC 29425

• Pathophysiology of Overactive Bladder.- Diagnosis of Overactive Bladder. The Placebo Effect in Overactive Bladder Syndrome.- Outcome Measures and Patient Expectations for Overactive Bladder.- National and International Guidelines in Overactive Bladder.- β3-Agonists for Overactive Bladder.- Combination Pharmacotherapy for Overactive Bladder.- Behavioral Therapy in Combination with Pharmacotherapy.- Pharmacotherapy for Nocturia.- Intravesical Chemodenervation and Toxins.- Other Treatment for Overactive Bladder, Including Intravesical.- Future Considerations in Overactive Bladder Pharmacotherapy.- Considerations in Pediatric Overactive Bladder.- Considerations in Male Overactive Bladder.- Considerations in the Medically Complex and Frail Elderly.- Individualizing Drug Therapy.